Skip to content

Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men

An Exercise Intervention on Metabolic Syndrome and Prostate Cancer Risk Among Black Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02379559
Acronym
STRONG
Enrollment
10
Registered
2015-03-05
Start date
2013-07-31
Completion date
2017-02-16
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Physical Activity, Prostate Cancer

Keywords

prostate cancer, African-American, Metabolic Syndrome, Exercise, Men's Health

Brief summary

The main purpose of this study is to examine the feasibility of an exercise intervention on metabolic syndrome (MetS) components and biomarkers related to prostate cancer in Black men with MetS who are at increased risk of prostate cancer.

Detailed description

The specific aim for the proposed study is to examine the feasibility and impact of a 6-month two-arm randomized controlled trial (RCT) on MetS components and biomarkers related to prostate cancer in Black men with MetS. Due to the striking racial disparities of prostate cancer, this proposal will focus on the impact of an aerobic and resistance exercise intervention on MetS and biomarkers related to prostate cancer in Black men. Specifically, our proposed clinical trial compares an aerobic and resistance exercise intervention to an attention control group among Black men.

Interventions

BEHAVIORALExercise

For the first 12-weeks, participants will come to our community based research office for up to 50 min/session, 3-days/week of supervised exercise. Exercise duration will increase from 75 min/wk at week 1 to 150 min/wk by week 4. Thereafter, men will maintain 150 min/wk of moderate-intensity physical activity.

BEHAVIORALAttention Control

We will provide weekly healthy lifestyle tips via text messages, and will include tips such as managing stressors in life and getting better sleep.

Sponsors

Georgetown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
40 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. African-American and/or Black men; 2. between the ages of 40-70 years; 3. waist circumference \>40 inches (102 cm); 4. with at least two of the following: elevated BP (≥ 130/85 mmHg); 5. elevated fasting glucose (≥ 100 mg/dL), reduced HDL cholesterol (\<50 mg/dL), or elevated triglycerides (≥ 150 mg/dL); 6. sedentary defined as \<60 minutes of recreation or work requiring modest PA/week; 7. be able to speak and read English; 8. able to provide meaningful consent (i.e., men with severe cognitive impairment will be excluded); 9. have no physical limitations that prevent from exercising; 10. and have access to a television and DVD player.

Exclusion criteria

1. history of cancer except nonmelanoma skin cancer; 2. current enrollment in another clinical trial or weight loss program; 3. inability to commit to the intervention schedule. Prior to randomization, participants will be required to have a signed authorization and medical clearance from their personal physician or our nurse practitioner.

Design outcomes

Primary

MeasureTime frameDescription
Waist circumference6-monthsWaist circumference will be measured at baseline, 3- and 6-months of the intervention

Secondary

MeasureTime frameDescription
Cardiovascular fitness test6-monthsBruce treadmill protocol will be used to determine VO2max at baseline, 3- and 6-months of the intervention.
Fasting glucose levels test6-monthsFasting blood sample via finger sticks will be administered by a phlebotomist to measure fasting glucose levels at baseline, 3- and 6-months of the intervention.
Dietary behaviors questionnaire6-monthsBlock 2005 Food Frequency Questionnaires (FFQ) at baseline, 3- and 6-months of the intervention
Quality of life questionnaire (SF-36)6-monthsShort Form 36 Health Survey (SF-36) will be administered at baseline, 3- and 6-months of the intervention.
Body Mass Index (BMI)6-monthsWeight (lbs) and height (inches) will be measured to calculate BMI at baseline, 3- and 6-months of the intervention.
Lipid level test6-monthsFasting blood sample via finger sticks will be administered by a phlebotomist to measure lipid levels at baseline, 3- and 6-months of the intervention.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026